[{"uuid": "79b31d4f-62ff-36d0-9a7c-86e039e1848a", "title": "Acurx Pharmaceuticals Says Selling Shareholders May Sell 2.6 Million Shares", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/acurx-pharmaceuticals-says-selling-shareholders-215551327.html", "providerPublishTime": 1738360551, "type": "STORY", "relatedTickers": ["ACXP"]}, {"uuid": "3e5406ff-f467-3aaf-bc38-ebf066b964fa", "title": "Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/acurx-pharmaceuticals-inc-announces-closing-220000898.html", "providerPublishTime": 1736287200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/vNEnKhGxEWFiuIfNjy4ptw--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/feee524751ff17e22492ddb7b68d37da", "width": 16, "height": 16, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/yFQjMbgOkOr2qYgAGOhB0Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/feee524751ff17e22492ddb7b68d37da", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACXP"]}, {"uuid": "c02ec98e-35de-31c4-97d3-091fd14510ef", "title": "Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/acurx-pharmaceuticals-inc-announces-2-223500421.html", "providerPublishTime": 1736202900, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/TlnepnSMgzcXzWvo5haHjw--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/ab744dfd413f29d506f6fca4bd35c731", "width": 16, "height": 16, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/yqRmLvbJ0NBbpVUaqXqmCQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/ab744dfd413f29d506f6fca4bd35c731", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACXP"]}, {"uuid": "91145e1b-5607-376d-ba22-61c16a8bdbe6", "title": "Acurx Launches $2.5 Million Registered Direct Offering; Shares Fall After-Hours", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/acurx-launches-2-5-million-230030757.html", "providerPublishTime": 1736204430, "type": "STORY", "relatedTickers": ["ACXP"]}, {"uuid": "382a54a1-92b7-3cc4-97b0-9bc9de867a51", "title": "Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI)", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/acurx-receives-positive-regulatory-guidance-133000707.html", "providerPublishTime": 1736170200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/k09dbDXJpt.TNnBi8JHMQQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/006e8c73d4e20df2453b7c68ee873e7d", "width": 16, "height": 16, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/nbaKnoevcojMP3tWNq5cUQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/006e8c73d4e20df2453b7c68ee873e7d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACXP"]}, {"uuid": "01f590d9-025f-3b97-aea5-d1653723293a", "title": "The Next Wave of Corporate Bitcoin Adoption Seems to Be on Its Way", "publisher": "CoinDesk", "link": "https://finance.yahoo.com/m/01f590d9-025f-3b97-aea5-d1653723293a/the-next-wave-of-corporate.html", "providerPublishTime": 1736250712, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/toeiJIYcKlvqPyWuOXfo9g--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/coindesk_75/8fd7d68873b324b4a122c7ae155537f3", "width": 1280, "height": 720, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/QikERWb5E8vsmca8gV9P7g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/coindesk_75/8fd7d68873b324b4a122c7ae155537f3", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["KULR", "MSTR"]}, {"uuid": "a1cdea69-a0ce-3a9e-ab4c-51513d50ea19", "title": "Are Medical Stocks Lagging  Abbott Laboratories (ABT) This Year?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/medical-stocks-lagging-abbott-laboratories-144008599.html", "providerPublishTime": 1735915208, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/UPInF06X6fJkTqeimnpZuQ--~B/aD03NDU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba", "width": 900, "height": 745, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/tlKVbaKmxwUbiS87UIMwQA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABT", "ACXP"]}, {"uuid": "bda4b1e0-cca1-335c-afbd-8b4948af6d46", "title": "Here's Why Acurx Pharmaceuticals (ACXP) Is a Great 'Buy the Bottom' Stock Now", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/heres-why-acurx-pharmaceuticals-acxp-145507108.html", "providerPublishTime": 1732805707, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Fs_R4sd8jCoOMib958Znmg--~B/aD02MDM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9", "width": 1000, "height": 603, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/D0XVH5pcxSB7uwJxgR.zVw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACXP"]}, {"uuid": "5ff399a0-04e0-3ea0-94f3-35d2122fa59b", "title": "Acurx Pharmaceuticals to Present at the Microcap Conference, January 28, 2025 - January 30, 2025", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/acurx-pharmaceuticals-present-microcap-conference-160000238.html", "providerPublishTime": 1733932800, "type": "STORY", "relatedTickers": ["ACXP"]}, {"uuid": "beebf70b-e3b7-3c86-b05a-578cb92c9cb3", "title": "Acurx Pharmaceuticals, Inc. Reports Third Quarter 2024 Results and Provides Business Update", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/acurx-pharmaceuticals-inc-reports-third-120000114.html", "providerPublishTime": 1731499200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/jZTlKjgzq39AhhwD0Ujy9Q--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/0acee424d62555a0f2cf4b64e1517f23", "width": 16, "height": 16, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/9RuIOCeR.0FWQMXu4cmy_A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/0acee424d62555a0f2cf4b64e1517f23", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACXP"]}, {"uuid": "6e7b1b74-b07d-3465-abf7-167bbdcac9a5", "title": "Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA Communications", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/acurx-updates-phase-3-readiness-130000907.html", "providerPublishTime": 1733749200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/pr1F4QYT6G.jYwUoP9Ov6Q--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/a1eda424f93549c3b1f0d04d44ce3404", "width": 16, "height": 16, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/xPVk6kbH.NaEIHpQ0RnHgQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/a1eda424f93549c3b1f0d04d44ce3404", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACXP"]}, {"uuid": "94a078de-16f9-3184-9c5b-6347541e4699", "title": "Acurx Pharmaceuticals Inc (ACXP) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...", "publisher": "GuruFocus.com", "link": "https://finance.yahoo.com/news/acurx-pharmaceuticals-inc-acxp-q3-070708447.html", "providerPublishTime": 1731568028, "type": "STORY", "relatedTickers": ["ACXP"]}, {"uuid": "f53b6730-d656-39e1-8905-513edb8f738c", "title": "Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/acurx-board-directors-approves-bitcoin-120100338.html", "providerPublishTime": 1732104060, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/QwsW8A2bKCnZj7LpYksNXw--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/8e4a940b6d448549b61f19d3d4569f0e", "width": 16, "height": 16, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/yHRGgFijZ0_7vbriHQPqwg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/8e4a940b6d448549b61f19d3d4569f0e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACXP"]}, {"uuid": "1f7af1a7-8bc0-3558-aa50-7ee90c197f21", "title": "Acurx Sponsored and Participated in the Peggy Lillis Foundation Inaugural CDI Scientific Symposium and Presented Ibezapolstat Ph2b Clinical Data Update", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/acurx-sponsored-participated-peggy-lillis-120000093.html", "providerPublishTime": 1731931200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/KZqZ4BLciOQ1qskGSOgo8Q--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/092953eded6c11321662ebd647353878", "width": 16, "height": 16, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/_92amN5e3h0zBT.0OCcfdQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/092953eded6c11321662ebd647353878", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACXP"]}, {"uuid": "1dd6c1a6-3644-3a22-bd47-ca8c03817d06", "title": "DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/dealflow-events-unveils-first-wave-120000736.html", "providerPublishTime": 1732708800, "type": "STORY", "relatedTickers": ["ASNS", "BETR", "BETRW", "ALCO", "ABL", "ABLLW", "FUFU", "FUFUW", "IPA", "ACXP", "DDOSF", "ABEO", "ALTS", "DUOT", "EEIQ", "ACU", "GRF.V", "ESGH"]}, {"uuid": "9c08d889-e6a8-31af-b9cd-249f97e9ab1d", "title": "Bitcoin Buying Plans Are Supercharging Stocks. Is This a Michael Saylor Redux \u2014 or Another 'Long Island Iced Tea' Fad?", "publisher": "CoinDesk", "link": "https://finance.yahoo.com/m/9c08d889-e6a8-31af-b9cd-249f97e9ab1d/bitcoin-buying-plans-are.html", "providerPublishTime": 1732557288, "type": "STORY", "relatedTickers": ["MSTR"]}, {"uuid": "1e7e8c20-da6e-3b0e-9a65-5153263462ef", "title": "Bitcoin Briefly Eclipses $99K\u2014Why Investors Just Can't Get Enough", "publisher": "Investopedia", "link": "https://finance.yahoo.com/m/1e7e8c20-da6e-3b0e-9a65-5153263462ef/bitcoin-briefly-eclipses.html", "providerPublishTime": 1732224110, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/0Z.xOaQI2xwWFJBLT5Xnkg--~B/aD0zNjYzO3c9NTQ5NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/investopedia_245/4f01cfab679051798258f81ea7c0d5ca", "width": 5495, "height": 3663, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/A5BAuwKbGoTiOQwL2JGlbg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/investopedia_245/4f01cfab679051798258f81ea7c0d5ca", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["MSTR"]}, {"uuid": "3c6a2125-6904-3055-a271-fc96242d5e5a", "title": "Alcon Inc (ALC) Q3 2024 Earnings Call Highlights: Record Cash Flow and Strategic Product ...", "publisher": "GuruFocus.com", "link": "https://finance.yahoo.com/news/alcon-inc-alc-q3-2024-070700340.html", "providerPublishTime": 1731568020, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/zVP5z3y.noqNTl69Thm1ww--~B/aD02NTt3PTI1MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/us.finance.gurufocus/761cb82bc0d82c3d63aadfdf42e80033", "width": 250, "height": 65, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/ehrBuyMLTdEEA64.LgOutg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/761cb82bc0d82c3d63aadfdf42e80033", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALC.SW"]}, {"uuid": "75593f97-02c9-3622-abe6-fd36d32f9514", "title": "MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000", "publisher": "Barrons.com", "link": "https://finance.yahoo.com/m/75593f97-02c9-3622-abe6-fd36d32f9514/microstrategy-copycats-are.html", "providerPublishTime": 1732296300, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/_kc6REYMS1JrAuV5bYtjfA--~B/aD02NTt3PTMyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/Barrons.com/12ea0f43d8f8307249a68d1cb2e0587e", "width": 320, "height": 65, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/5waH37HKuL3X52B3V2GWrw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/12ea0f43d8f8307249a68d1cb2e0587e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["MSTR", "ENLV", "ACXP", "HOTH"]}]